Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

No Respect

Rodney Dangerfield Wikimedia Commons In March 1967, for most of the adult population in North America, the most popular comedians were almost all television series personalities, such as Carol Burnett, Buddy Ebsen and Dick Van Dyke. ...
Streetwise Reports | May 5, 2020 |

Gold’s Major Reversal to Create the “Handle”

Gold just closed the month and quarter and its performance on the final day of both was very encouraging for the bulls. What’s going on and what changed? Let’s start with the big picture. Gold just moved to the November 2011 high and ...
Przemyslaw Radomski, CFA | July 2, 2020 |

Silver’s Valuable Insights Into the Upcoming PMs Rally

The analysis of the precious metals market isn’t just gold analysis – there are times when silver rises to the forefront of everyone’s attention. And we fully expect such a moment of the white metal stealing the spotlight to arrive shortly. Wh...
Przemyslaw Radomski, CFA | February 18, 2020 |

Here Be Dragons, 'Hic Sunt Dracones'

We have sailed off the map of the known world into totally uncharted waters. No one, including me, knows exactly where we are or where we are headed. But hic sunt dracones is an excellent warning, here be dragons. If I was still flying and needed to give a brief to my...
Streetwise Reports | March 17, 2020 |

Use It Up, Make Do, or Do Without

We entered a depression that is going to turn our world upside down. Before it ends the general stock market will be down 85-92%, banks will close and governments fall. People still do not realize the impact of the coronavirus. It will kill tens of millions of people in t...
Streetwise Reports | March 27, 2020 |

Inovio Pharma Awarded $9M Development Grant for Coronavirus Vaccine

Inovio Pharmaceuticals' shares rose 30%, setting a new 52-week high price, after the firm reported it received a grant of up to $9 million to develop a vaccine against the coronavirus. Among ongoing worldwide concerns, biotechnology firm Inovio Pharmaceuticals Inc. (IN...
Streetwise Reports | January 28, 2020 |

Vir Biotech Shares Rise on Joint Research Efforts with the NIH to Combat Coronaviruses

Vir Biotechnology shares traded higher after the company reported that it has entered into a research collaboration with the National Institutes of Health Vaccine Research Center on antibodies against coronaviruses including SARS-CoV-2. Clinical-stage immuno...
Streetwise Reports | March 12, 2020 |

iBio Shares Trade Up 40% After Announcing Development of Proprietary COVID-19 Vaccine Candidates

iBio Inc. shares traded higher after the company reported that it has filed several provisional patents for its SARS-CoV-2 Virus-Like Particle platform with the U.S. Patent and Trademark Office. Biologics contract manufacturing firm iBio Inc. (IBIO:NYSE.Ame...
Streetwise Reports | March 19, 2020 |

Vir Partners with Samsung Biologics on Large-Scale Manufacture of COVID-19 Antibody Treatment

Vir Biotechnology reported it has entered into an agreement with Samsung Biologics valued at $362 million for large-scale manufacture of SARS-COV-2 antibodies for potential COVID-19 treatment. Though U.S. markets are closed for the Good Friday holiday, Samsung Biologics shar...
Streetwise Reports | April 13, 2020 |

Barrick, First Majestic, Osino Resources, Scottie Resources - preparing for helicopter money

In the 1960s, the Nobel Prize winner Milton Friedman, an influential economist in the USA, studied various models of monetary policy. One of the models of how the Federal Reserve can boost consumption and achieve its inflation targets while preventing deflation would be by iss...
Mario Hose | March 18, 2020 |
1 2 3 4